Compleat DHA ONE Chewable Softgel Fruit Flavored
Product Type
supplement
Packaging Size
Serving Size
1.0 Chewable Softgel(s),
UPC
367112501314
Ingredients
dha | 135.0 | mg |
other omega-3s | 71.2 | mg |
epa | 33.8 | mg |
Description
Lactating Pregnant Women Adult Female (18 - 50 Years) NP How supplied: TriCare Prenatal Compleat Multivitamin/Mineral Tablets and Omega-3 Chewable Softgels for oral administration are supplied as light blue, file coated tablets debossed MP 101 with a partial bisect through the tablet on one side and as pink chewable softgels. Chewable softgels are in a child-resistant plastic bottle of 30 chewable softgels (NDC 67112-601-30). NDC 67112-501-31
Rx only Store at controlled room temperature 15 degrees - 30 degrees C (59 degrees - 86 degrees F). Dosage and administration: One tablet and one chewable softgel daily or as directed by a physician.
Formulation
Delicious fruit flavored chewable softgel
DHA without the fishy aftertaste Multivitamin/Mineral Tablet + DHA ONE Chewable Softgel Essential nutrition for the 3 vital stages of pregnancy. Indications and usage: TriCare Prenatal Compleat is indicated to provide vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and non-lactating mother. It is also useful for improving nutritional status prior to conception.
Precautions
Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Notice: Contact with moisture may product surface discoloration or erosion of the tablet and chewable softgel. To report a serious adverse event or obtain product information, call 877-803-8235. Warning: Ingestion of more than .3 grams of Omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Adverse reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid. Keep this and all drugs out of the reach of children Administration of Omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have inherited or acquired predisposition to bleeding.